Global H1N1 Vaccines Market 2018 - Industry Analysis, Trends, Market Size and Forecasts up to 2024
The "H1N1 Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
DUBLIN, Feb. 6, 2019 /PRNewswire/ --
The "H1N1 Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report on global H1N1 vaccines market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global H1N1 vaccines market to grow with a CAGR of 5.2% over the forecast period of 2018-2024. The study on H1N1 vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
H1N1 virus or swine flu is an infectious disease in humans caused by the swine H1N1 virus. H1N1 virus affects various species such as birds, swine, horses and other animals. When a person is infected with this virus, it causes damage to the respiratory system including nose, lungs and throat. This virus is contagious and can spread from human to human.
H1N1 virus is a ribonucleic acid virus belonging to the Orthomyxoviridae family. Influenza A viruses can be categorized on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. The virus used hemagglutinin element to bind to host cell receptors. This simplifies viral entry into the host cell. Neuraminidase protein enzymatically slices terminal sialic acid, which is present in mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Individuals with medical conditions such as blood disorders, asthma, kidney disorders, liver disorders, chronic lung disease, and neurodevelopmental and neurological conditions are at a high risk of being infected with this virus.
The rising incidences of swine flu, need for H1N1 vaccination is increasing worldwide. The antivirals are given to an individual through vaccine to prevent or reduce the effect of the virus. Additionally, the risk of respiratory diseases, and immune deficient diseases is increased among the geriatric population; thus increasing the risk factor for acquiring H1N1 influenza. Moreover, advancement in vaccine technologies has increased research in this field and substantial government support are likely to drive the growth of the market. On the other hand, lack of skilled medical professionals to and lack of alertness are the factors hampering the growth of the market.
Among the geographies, North America is expected to be the largest market for H1N1 vaccine followed by Europe due to the presence of developed research organization in this region. While, Asia-Pacific is expected to grow fast during the forecast period, owing to the increasing awareness about the diseases, rising cases of this infection and growing government support in countries like China and India is likely to augment the growth in this region.
Key Topics Covered:
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global H1n1 Vaccines Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global H1n1 Vaccines Market
4. Global H1n1 Vaccines Market by Route of Administration
4.1. Intranasal Vaccines
4.2. Intradermal Vaccines
4.3. Intramuscular Vaccines
5. Global H1n1 Vaccines Market by Region 2018-2024
5.1. North America
5.2. Europe
5.3. Asia-Pacific
5.4. RoW
6. Company Covered
6.1. Abbott
6.2. Baxter International
6.3. Sanofi
6.4. Gsk
6.5. Pfizer
6.6. Mitsubishi Tanabe Pharma
6.7. Hualan Biological Engineering
6.8. Cipla
6.9. Merck
6.10.Sinovac Biotech
For more information about this report visit https://www.researchandmarkets.com/research/d52pg3/global_h1n1?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-h1n1-vaccines-market-2018---industry-analysis-trends-market-size-and-forecasts-up-to-2024-300790728.html
SOURCE Research and Markets